Argent Biopharma Ltd RGT
News
Trading Information
- Previous Close Price
- A$0.03
- Day Range
- A$0.03–0.03
- 52-Week Range
- A$0.03–0.11
- Bid/Ask
- A$0.03 / A$0.04
- Shares Outstanding
- 116.61M
- Market Cap
- A$3.27M
- Volume/Avg
- 168,685 / 679,027
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 16.14
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Argent Biopharma Ltd is a revenue-generating, clinical-stage biopharmaceutical company focused on the development and commercialization of nano-engineered therapeutics targeting neurological and immunemediated disorders. Its assets, CannEpil and CimetrA, are for drug-resistant epilepsy and inflammatory conditions, respectively. The company leverages proprietary nano-delivery technologies designed to optimize bioavailability and tissue penetration, including across the blood-brain barrier and pulmonary interfaces. The company operates in a single segment. Geographically, it operates in Malta, Slovenia, UK, and Australia, with the majority of revenue deriving from Slovenia.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.argentbiopharma.com
Valuation
|
Metric
|
RGT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 16.14 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
RGT
|
|---|---|
Quick Ratio | 0.19 |
Current Ratio | 0.21 |
Interest Coverage | — |
Quick Ratio
RGT
Profitability
|
Metric
|
RGT
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
RGT
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|tFX%^?Xg | LOCK|#MRxX | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|ssjj^>%L | LOCK|<?SZR | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|?^lJyK | LOCK|%B> | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|lNN@^xWt | LOCK|?XR | $29B | |||
| Viatris Inc
VTRS
| LOCK|Lj?>h>> | LOCK|xW$ | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|T%$ | LOCK|$? | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|YT?$<x | LOCK|dY | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|#LBqDpq | LOCK|s$^ | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|>fGkQBY | LOCK|JCBS$ | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|Xwr!QYv | LOCK|%N | $2B |
United States